Posters & Publications

Author(s)PublicationTitleDate
Powers et al.American Society for Reproductive Medicine (ASRM)Incorporating Direct Patient Health Outcomes into Clinical Trials for the Prevention of Urogenital Chlamydia Trachomatis Infection: Analysis of a Novel Endpoint in a Clinical Trial of EVO100 (EVO-003) View Poster October 2021
Chappell et al.American Society for Reproductive Medicine (ASRM)Timing of On-Study Pregnancies with a Vaginal pH Modulator in the Phase 3 AMPOWER Trial View Poster October 2021
Surowitz et al.American Society for Reproductive Medicine (ASRM)Side Effects by Frequency of Use with EVO100 Vaginal Gel: Results From The Phase 2B/3 AMPREVENCE Trial. View Poster October 2021
Thomas et al.National Community Oncology Dispensing Association (NCODA)Sexual Satisfaction with Phexxi, A Hormone-Free Vaginal Contraceptive: Results From The AMPOWER Clinical Trial View Poster April 2021
Portman D, et al.Advances in TherapyVariability in Contraceptive Clinical Trial Design and the Challenges in Making Comparisons Across Trials View Poster September 2021
Robert Morlock, PhDInternational Society for Pharmacoeconomics and Outcomes Research (ISPOR)Assessing the Understandability and Importance of Patient Reported Outcomes Impacting Adherence and Outcomes of a Non-Hormonal Vaginal Microbicide to Protect Against Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (GC) View Poster May 2021
Eisenberg, et al.American Clinical and Scientific Meeting of the American College of Obstetricians & Gynecologists (ACOG)Compliance with Vaginal PH Modulator in the Phase 3 Ampower Contraceptive Trial View Poster May 2021
Maximos, et al.American Clinical and Scientific Meeting of the American College of Obstetricians & Gynecologists (ACOG)Pregnancy Intendedness with Vaginal PH Modulator: Results from the Phase 3 Ampower Trial View Poster May 2021
Chappell, et al.Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecology (ACOG)Perfect-Use Pregnancy Rates with Vaginal pH Regulator: Efficacy Results from AMPOWER View Poster October 2020
Thomas, et al.Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecology (ACOG)Sexual Satisfaction With Vaginal pH Regulator: Results From The AMPOWER Clinical Trial View Poster October 2020
Maximos, et al.Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecology (ACOG)Genitourinary Side Effects With Vaginal pH Regulator: Results From AMPOWER View Poster October 2020
Thomas, et al.American Society for Reproductive Medicine (ASRM)Sexual Satisfaction With a Vaginal pH Regulator (EVO100): Results From the AMPREVENCE Clinical Trial View Poster October 2020
Thomas, et al.American Society for Reproductive Medicine (ASRM)Characterization of Women According to Their Sexual Satisfaction After Treatment With the Novel Vaginal pH Regulator (VPR™) During the AMPOWER Study View Poster October 2020
Howard, et al.Nurse Practitioners in Women’s Health (NPWH)A Comparison of Women Who Completed or Discontinued the AMPOWER Study, a Phase 3 Contraceptive Trial for Vaginal pH Regulator View Poster October 2020
Mena, et al.Society for Family Planning (SFP)Impact of Product Adherence and Condom Use on Rates of Urogenital Re-infection with Chlamydia Trachomatis or Neisseria Gonorrhoeae in the AMPREVENCE Phase 2b/3 Clinical Trial View Poster October 2020
Maximos, et al.Society for Family Planning (SFP)Characterization of Women According to Pregnancy Status Following Treatment with VPR During the AMPOWER Study View Poster October 2020
Chappell, et al.STD Prevention Conference (STDC)Efficacy and Safety of Vaginal pH Regulator for Prevention of Chlamydia and Gonorrhea View Poster September 2020
Thomas, et al.Contraception XA Novel Vaginal pH Regulator: Results From The Phase 3 AMPOWER Contraception Clinical Trial View Poster April 2020
Cason, et al.Nurse Practitioners in Women’s Health (NPWH) Healthcare ConferenceEfficacy and Safety of a Vaginal pH Regulator: Results from the Phase 3, AMPOWER Clinical Trial View Poster Oct. 2019
Thomas, et al.American Society of Reproductive Medicine (ASRM)Women’s Satisfaction with the Vaginal pH Regulator (VPRTM): Results From the Phase 3 AMPOWER Trial View Poster Oct. 2019
Culwell K, et al.Fertility and SterilityA randomized, placebo-controlled pilot study to determine the effect and duration of Acidfrom gel (Amphora) on vaginal pH View Poster Oct. 2017
Friend D2nd International Conference on Reproductive HealthAmphora vaginal gel: An on-demand contraceptive with anti-STI (MPT) potential View Poster Dec. 2016
Thomas M, et al.Contraception JournalGynecologic infections and colposcopy fidings from a phase 3 efficacy and safety study of a contracpetive vaginal gel compared with nonoxynol-9 View Poster Oct. 2016
Barnhard K, et al.Obstetrics & GynecologyContraceptive efficacy, safety, and acceptability of Amphora (an acid-buffering vaginal gel) and Conceptrol View Poster May 2016
Bayer L, et al.Contraception JournalACIDFORM: a review of the evidence View Poster July 2014

Evofem assumes no responsibility for the accuracy of any information or data contained on any third party website. Evofem has not independently verified the accuracy of such information or data, and there can be no assurance as to the accuracy of any such information or data. Links to this information and data are provided for informational purposes only.